BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes
2021 · Cancer Cell International · 65 citations
https://doi.org/10.1186/s12935-021-01908-w
X
Xiaolu Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
88
Papers
1.6K
Citations
23
h-index
48
i10-index
Xiaolu Li is an academic researcher from Qingdao University. The author has contributed to research in topics: Protein Degradation and Inhibitors & Ubiquitin and proteasome pathways & Advanced biosensing and bioanalysis techniques. The author has an h-index of 23, co-authored 75 publications.
ORCID: 0000-0002-9474-2931Papers by this author
worksBRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma
2022 · Cell & Bioscience · 25 citations
https://doi.org/10.1186/s13578-022-00769-8
Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia
2022 · Journal of Experimental & Clinical Cancer Research · 20 citations
https://doi.org/10.1186/s13046-022-02428-9
BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia
2022 · Journal of Immunology Research · 17 citations
https://doi.org/10.1155/2022/7912484
C646 modulates inflammatory response and antibacterial activity of macrophage
2019 · International Immunopharmacology · 16 citations
https://doi.org/10.1016/j.intimp.2019.105736
METTL14 promotes neuroblastoma formation by inhibiting YWHAH via an m6A-YTHDF1-dependent mechanism
2024 · Cell Death Discovery · 10 citations
https://doi.org/10.1038/s41420-024-01959-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat